All the news Showing 10 of 45 articles from: Diagnosis and monitoringGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Birth cohort screening and linkage to care for HCV treatment still weak in United States Keith Alcorn / 18 November 2016 Grave weaknesses in hepatitis C screening and linkage to care are still widespread in the United States and threaten to leave a large proportion of baby boomers with hepatitis C ... Even low levels of alcohol consumption increase the risk of liver cancer for people with HCV infection with compensated cirrhosis Michael Carter / 05 September 2016 Low-to-moderate alcohol consumption is associated with an increased risk of liver cancer for people with hepatitis C virus (HCV) infection with compensated cirrhosis, investigators from Belgium report in the Journal of Hepatology. Five-year incidence ... Hepatitis C antigen testing could eliminate need for two-step HCV testing, reduce cost of access Keith Alcorn / 21 June 2016 Testing for hepatitis C virus (HCV) core antigen could eventually replace the current two-step procedure for diagnosing chronic hepatitis C infection in lower- and middle-income countries, speeding up access to treatment and improving ... Age- and risk-based HCV screening will leave significant proportion of infections undiagnosed Michael Carter / 13 March 2016 Screening emergency department patients for hepatitis C virus (HCV) based on birth cohort and risk profile might mean that a quarter of undiagnosed infections would remain undetected, according to United States research published ... Improving referral from primary care boosts hepatitis C treatment uptake in UK study Keith Alcorn / 27 January 2016 Improving referral to hepatitis specialists and assessment by specialists resulted in almost four times as many people beginning hepatitis C treatment in one year at hospitals in Nottingham, the findings of a ... US study provides 'real world' evidence about which patients with hepatitis C should be prioritised for therapy Michael Carter / 19 October 2015 For patients with hepatitis C virus (HCV) mono-infection, baseline fibrosis stage is strongly predictive of the medium-term risk of serious liver disease and death, investigators from the United States report in the ... Another study confirms detrimental effects of delaying hepatitis C treatment Liz Highleyman / 05 May 2015 Deferring antiviral therapy for hepatitis C until a person progresses to advanced liver disease has clear drawbacks including lower treatment effectiveness and an increased risk of clinical events and death, according to ... New EASL guidelines prioritise interferon-free hepatitis C treatment Liz Highleyman / 28 April 2015 The European Association for the Study of the Liver (EASL) released its latest hepatitis C treatment guidelines at the 50th International Liver Congress which took place last week in Vienna, Austria. The ... Advanced liver damage is common in people with undiagnosed hepatitis C in US survey Keith Alcorn / 25 April 2015 Around one in five of people with hepatitis C in the United States who do not know of their infection may already have advanced liver damage and be in urgent need of ... Many hepatitis C patients with cirrhosis or advanced fibrosis face liver failure and liver cancer Liz Highleyman / 07 January 2015 Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within five years, and 23% and 11%, respectively, died, according to a study presented ... ← Prev12345Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive